The Correlation of Treatment Phases with Life’s Quality of Multidrug-resistant Tuberculosis Patient in Dr. H. Abdul Moeloek Hospital Lampung


  • Muhammad Rifki Pratama
  • Asep Sukohar
  • Khairun Nisa Berawi



Multidrug-resistant tuberculosis, quality of life, treatment phases


Tuberculosis (TB) is the number one infectious disease in the world as the most frequent cause of death. TB infects 10 million people each year and becomes the 10th highest cause of death in the world.Multidrug-resistant Tuberculosis (MDR-TB) is a type of TB germ resistance against at least two first-line anti-tuberculosis (OAT) drugs. MDR-TB treatment certainly takes longer than 18 months. This very long treatment can affect the quality of life of MDR-TB patients. This study is to determine the correlation between the treatment phases with the quality of life of patients with Multidrug-resistant Tuberculosis in Dr. H. Abdul Moeloek Hospital Lampung Province. This study used 68 respondents who had been diagnosed with MDR-TB by pulmonary specialists. Primary data was taken using SF-36 questionnaire to measure the quality of life of MDR-TB patients, then secondary data based on the treatment phases using the medical record of the patient who had filled out the questionnaire. The data is processed and analyzed by the program in the computer. Data were tested by chi-square test and the results were obtained from 30 respondents in the initial treatment phases, 22 people (73.3%) quality of life was poor and 8 people had good quality of life (26.7%), while from 38 respondents at the continued treatment phases, as many as 12 people (31.6%) quality of life is bad and 26 people have good quality of life (68.4%). The result of bivariate analysis showed the variable had a correlation with p-value=0,001. There is a correlation between the treatment phases with the quality of life of patients with Multidrug-resistant Tuberculosis in RSUD Dr. H. Abdul Moeloek.


WHO. 2017. Global Tuberculosis Report 2017. Switzerland: World Health Organization.

TBCTA. 2009. Implementing the WHO Policy on TB Infection Control in Health- Care Facilities, Congregate Settings and Households. Tuberculosis Coalition for Technical Assistance. (2): 151.

WHO. 2014. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. The Journal of Medical Association of Malawi. 19: 82–6.

Kemenkes RI. 2014. Profil Kesehatan Indonesia 2014. Jakarta: Kementerian Kesehatan RI.

PPTI. Jurnal Tuberkulosis Indonesia. Perkumpulan Pemberantasan Tuberkulosis Indonesia. 7: 16–19.

Mulyanto H. 2014. Hubungan lima indikator perilaku hidup bersih dan sehat dengan tuberkulosis. Jurnal Berkala Epidemiologi FK Unair. 2(3): 355–67.

Syahrini H. 2008. Tuberkulosis Paru Resistensi Ganda. Medan: Fakultas Kedokteran Universitas Sumatera Utara.

Peddireddy V. 2016. Quality of life, psychological interventions and treatment outcome in tuberculosis patients: The Indian scenario. Frontiers in Psychology. 7(OCT): 1–9.

Javaid A, Ahmad N, Sulaiman SAS, Basit A, Afridi AK, Jaber AAS., et al. 2016. Effects of multidrug-resistant tuberculosis treatment on patients health related quality of life: Results from a follow up study. PLOS ONE. 11(7): 1–16.

Mamani M, Majzoobi MM, Ghahfarokhi SM, Esna-Ashari F, Keramat F. 2014. Assessment of health-related quality of life among patients with tuberculosis in Hamadan, Western Iran. Oman Medical Journal. 29(2): 102–05.

Sugiyono. 2016. Metode Penelitian Kuantitatif, Kualitatif dan R&D. Bandung: PT Alfabet.

Mubtadi N, Putranto R, Setyohadi B, Rinaldi I. 2017. Reliability and Validity Test Of Indonesian Version Short Form

Quality of Life Questionnaire in Rheumatoid Arthritis Patient. Jurnal Penyakit Dalam Indonesia. 4(3): 105–11.

Kemenkes RI. 2016. Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016 tentang Penanggulangan Tuberkulosis. Jakarta: Kementerian Kesehatan RI.

Kemenkes RI. 2014. Petunjuk Teknis Manajemen Terpadu Pengendalian Tuberkulosis Resisten Obat. Jakarta: Kementerian Kesehatan RI.

Nawas, A. 2010. Penatalaksanaan MDR- TB dan Strategi DOTS Plus. Jakarta: FKUI RSUP Persahabatan.

Khan S, Tangiisuran B, Imtiaz A, Hadzliana Z. 2017. Health Status and Quality of Life in Tuberculosis: Systematic Review of Study Design, Instruments, Measuring Properties and Outcomes. Health Science Journal. 11(1): 1–10.

Soepandi PZ. 2010. Diagnosis dan Penatalaksanaan TB-MDR. Cermin Dunia Kesehatan. Jakarta: FKUI - RSUP Persahabatan.

Louw JS, Mabaso M, Peltzer K. 2016. Change in health-related quality of life among pulmonary tuberculosis patients at primary health care settings in South Africa: A prospective cohort study. PLOS ONE. 11(5): 1–13.

Tinartayu S, Udji B, Riyanto D. 2015. SF-36 sebagai Instrumen Penilai Kualitas Hidup Penderita Tuberkulosis ( TB ) Paru. Mutiara Medika. 15(1): 7–14.

Unalan D, Soyuer F, Ceyhan O, Basturk M, Ozturk A. 2008. Is the quality of life different in patients with active and inactive tuberculosis. The Indian journal of tuberculosis. 55(3): 127–37.



How to Cite

Muhammad Rifki Pratama, Asep Sukohar, & Khairun Nisa Berawi. (2020). The Correlation of Treatment Phases with Life’s Quality of Multidrug-resistant Tuberculosis Patient in Dr. H. Abdul Moeloek Hospital Lampung . Medical Profession Journal of Lampung, 10(1), 171-174.




Most read articles by the same author(s)

1 2 > >>